

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.36088371 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.52246650 |
| 3 | glomerular filtration (GO:0003094) | 6.24035951 |
| 4 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 6.23420204 |
| 5 | negative regulation of glucose import (GO:0046325) | 6.03638495 |
| 6 | signal peptide processing (GO:0006465) | 5.89503507 |
| 7 | regulation of respiratory burst (GO:0060263) | 5.71809512 |
| 8 | renal filtration (GO:0097205) | 5.54945381 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.46308739 |
| 10 | B cell receptor signaling pathway (GO:0050853) | 5.31481671 |
| 11 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.24799824 |
| 12 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.96032565 |
| 13 | negative regulation of glucose transport (GO:0010829) | 4.89181340 |
| 14 | Fc receptor signaling pathway (GO:0038093) | 4.86434484 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.82531762 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 4.69031230 |
| 17 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.54852482 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 4.43500714 |
| 19 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.38618410 |
| 20 | cellular response to zinc ion (GO:0071294) | 4.28096210 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.20084065 |
| 22 | regulation of B cell proliferation (GO:0030888) | 4.12723880 |
| 23 | regulation of B cell differentiation (GO:0045577) | 4.10391064 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07272941 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97360762 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.97360762 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.95012297 |
| 28 | immune response-activating signal transduction (GO:0002757) | 3.94390316 |
| 29 | fucose catabolic process (GO:0019317) | 3.88423596 |
| 30 | L-fucose metabolic process (GO:0042354) | 3.88423596 |
| 31 | L-fucose catabolic process (GO:0042355) | 3.88423596 |
| 32 | germinal center formation (GO:0002467) | 3.84442193 |
| 33 | positive regulation of protein homooligomerization (GO:0032464) | 3.68616899 |
| 34 | regulation of antigen processing and presentation (GO:0002577) | 3.59596227 |
| 35 | activation of immune response (GO:0002253) | 3.57674774 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.49269877 |
| 37 | B cell mediated immunity (GO:0019724) | 3.46445784 |
| 38 | negative regulation of cell killing (GO:0031342) | 3.46020755 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46020755 |
| 40 | chronic inflammatory response (GO:0002544) | 3.41492278 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40446387 |
| 42 | regulation of integrin activation (GO:0033623) | 3.36090170 |
| 43 | regulation of cellular extravasation (GO:0002691) | 3.34712186 |
| 44 | response to interleukin-15 (GO:0070672) | 3.31056086 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30806225 |
| 46 | positive regulation of immunoglobulin production (GO:0002639) | 3.29301109 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.28362977 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.28362977 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27753724 |
| 50 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.27459973 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.25871940 |
| 52 | response to type I interferon (GO:0034340) | 3.25858428 |
| 53 | detection of other organism (GO:0098543) | 3.21773811 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.18644066 |
| 55 | cellular extravasation (GO:0045123) | 3.17901585 |
| 56 | proline biosynthetic process (GO:0006561) | 3.16984651 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16351549 |
| 58 | B cell proliferation (GO:0042100) | 3.15758442 |
| 59 | defense response to protozoan (GO:0042832) | 3.14743299 |
| 60 | positive regulation of macrophage cytokine production (GO:0060907) | 3.12395473 |
| 61 | detection of bacterium (GO:0016045) | 3.12036818 |
| 62 | cellular response to ethanol (GO:0071361) | 3.10364209 |
| 63 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.10131765 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.09491805 |
| 65 | regulation of germinal center formation (GO:0002634) | 3.01328633 |
| 66 | complement activation, classical pathway (GO:0006958) | 27.2567811 |
| 67 | complement activation (GO:0006956) | 20.9054643 |
| 68 | detection of external biotic stimulus (GO:0098581) | 2.94408835 |
| 69 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.91603083 |
| 70 | negative regulation of B cell activation (GO:0050869) | 2.90849595 |
| 71 | production of molecular mediator of immune response (GO:0002440) | 2.89763530 |
| 72 | wound healing, spreading of epidermal cells (GO:0035313) | 2.89065569 |
| 73 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.88628645 |
| 74 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.87649239 |
| 75 | negative thymic T cell selection (GO:0045060) | 2.86386414 |
| 76 | embryonic process involved in female pregnancy (GO:0060136) | 2.85176202 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85099465 |
| 78 | regulation of B cell activation (GO:0050864) | 2.83154692 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.83004064 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 2.82597627 |
| 81 | eosinophil chemotaxis (GO:0048245) | 2.81637735 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.81558006 |
| 83 | macrophage activation involved in immune response (GO:0002281) | 2.78074067 |
| 84 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.77666445 |
| 85 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.76883324 |
| 86 | respiratory burst (GO:0045730) | 2.75373129 |
| 87 | tissue homeostasis (GO:0001894) | 2.74553700 |
| 88 | cellular response to interleukin-15 (GO:0071350) | 2.74009239 |
| 89 | protein-chromophore linkage (GO:0018298) | 2.73429303 |
| 90 | cellular response to interferon-gamma (GO:0071346) | 2.70454332 |
| 91 | positive regulation of B cell proliferation (GO:0030890) | 2.69571994 |
| 92 | regulation of T cell migration (GO:2000404) | 2.69016444 |
| 93 | positive regulation of protein oligomerization (GO:0032461) | 2.68802508 |
| 94 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68758958 |
| 95 | antibacterial humoral response (GO:0019731) | 2.68070667 |
| 96 | response to protozoan (GO:0001562) | 2.68023853 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67706494 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67706494 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.67706494 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67706494 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 2.67706494 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67706494 |
| 103 | lymph node development (GO:0048535) | 2.67226613 |
| 104 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.66058962 |
| 105 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63579840 |
| 106 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.63424694 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.61516017 |
| 108 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.61106060 |
| 109 | negative T cell selection (GO:0043383) | 2.59013616 |
| 110 | peptidyl-asparagine modification (GO:0018196) | 2.58834471 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58062989 |
| 112 | positive regulation of Rap GTPase activity (GO:0032854) | 2.57575815 |
| 113 | Golgi transport vesicle coating (GO:0048200) | 2.57221475 |
| 114 | COPI coating of Golgi vesicle (GO:0048205) | 2.57221475 |
| 115 | maternal placenta development (GO:0001893) | 2.56300109 |
| 116 | antimicrobial humoral response (GO:0019730) | 2.54750665 |
| 117 | I-kappaB phosphorylation (GO:0007252) | 2.53144680 |
| 118 | mast cell activation (GO:0045576) | 2.49341823 |
| 119 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.47148771 |
| 120 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.45051505 |
| 121 | protein N-linked glycosylation (GO:0006487) | 2.41625412 |
| 122 | doxorubicin metabolic process (GO:0044598) | 2.39672735 |
| 123 | daunorubicin metabolic process (GO:0044597) | 2.39672735 |
| 124 | polyketide metabolic process (GO:0030638) | 2.39672735 |
| 125 | xenobiotic catabolic process (GO:0042178) | 2.39635121 |
| 126 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.39318302 |
| 127 | regulation of B cell apoptotic process (GO:0002902) | 2.38491785 |
| 128 | regulation of immunoglobulin production (GO:0002637) | 2.38254155 |
| 129 | positive regulation of nuclease activity (GO:0032075) | 2.36822210 |
| 130 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.36643458 |
| 131 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.33370655 |
| 132 | cellular response to unfolded protein (GO:0034620) | 2.32086058 |
| 133 | thymic T cell selection (GO:0045061) | 2.31934303 |
| 134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.30894301 |
| 135 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.27642224 |
| 136 | N-glycan processing (GO:0006491) | 2.25931729 |
| 137 | regulation of nuclease activity (GO:0032069) | 2.24611589 |
| 138 | mature B cell differentiation (GO:0002335) | 2.23507066 |
| 139 | regulation of macrophage cytokine production (GO:0010935) | 2.23434553 |
| 140 | defense response to Gram-negative bacterium (GO:0050829) | 2.22518954 |
| 141 | intestinal epithelial cell development (GO:0060576) | 2.22467311 |
| 142 | regulation of Rap GTPase activity (GO:0032317) | 2.21449818 |
| 143 | regulation of superoxide anion generation (GO:0032928) | 2.20467588 |
| 144 | B cell homeostasis (GO:0001782) | 2.19557358 |
| 145 | N-acetylneuraminate metabolic process (GO:0006054) | 2.19404878 |
| 146 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.18150186 |
| 147 | T cell selection (GO:0045058) | 2.17346310 |
| 148 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.15935616 |
| 149 | negative regulation of interleukin-10 production (GO:0032693) | 2.15278254 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.13234184 |
| 151 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.10937596 |
| 152 | mannose metabolic process (GO:0006013) | 2.10739143 |
| 153 | neutrophil activation involved in immune response (GO:0002283) | 2.10425074 |
| 154 | T cell lineage commitment (GO:0002360) | 2.09146965 |
| 155 | ER-nucleus signaling pathway (GO:0006984) | 2.08978411 |
| 156 | protein activation cascade (GO:0072376) | 13.6197117 |
| 157 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.5455492 |
| 158 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.5455492 |
| 159 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.5455492 |
| 160 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.4057710 |
| 161 | retina homeostasis (GO:0001895) | 10.6764960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.44573524 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.84315551 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.20314975 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.96259438 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.69124537 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.20059973 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.98598537 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.68437436 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.55554820 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44496948 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.08815266 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03354571 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.99621501 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.85404259 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79411384 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72794478 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58813641 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.48466906 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45567668 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39506653 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29834477 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26648160 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20204866 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17671131 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.12906467 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.11643813 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08165733 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03943994 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01605677 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01440474 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00462017 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93982911 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89850604 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89270874 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86299259 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85395679 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84974237 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81536387 |
| 39 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.78575157 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75683962 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.68813244 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68269252 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67698513 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.66989469 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66355928 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63815300 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59867870 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.56036620 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55008232 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54752549 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53492946 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49081557 |
| 53 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.43138038 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41203893 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38982908 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38292276 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37910095 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37113264 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36665890 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35046710 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27811495 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25301892 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25227566 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23413051 |
| 65 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.22341027 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22292483 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21409380 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.20485697 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20341230 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19701821 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.19050489 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18482231 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16117239 |
| 74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15600411 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15315347 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13279450 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11663509 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10817394 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09784677 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09727661 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09716840 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09073120 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06372689 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06291551 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05853047 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05557734 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03734785 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00513614 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00133753 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99861933 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99640586 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99561921 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98448521 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96665459 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96151118 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95399355 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95344423 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94175082 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93657451 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92735375 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92172597 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91469432 |
| 103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91213401 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90172768 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89924445 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89917233 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89744197 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88891007 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87006273 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85802923 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84609238 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84321138 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83901584 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83302216 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83095735 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82097362 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79671542 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79389410 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78618027 |
| 120 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.77885768 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77830516 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77453631 |
| 123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77434960 |
| 124 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76874777 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74882172 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74677955 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.74424803 |
| 128 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74337693 |
| 129 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73538255 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70082944 |
| 131 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67710715 |
| 132 | GATA3_26560356_Chip-Seq_TH1_Human | 0.67536268 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66755988 |
| 134 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.65562049 |
| 135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62031208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.43121613 |
| 2 | MP0003724_increased_susceptibility_to | 5.02275862 |
| 3 | MP0001800_abnormal_humoral_immune | 4.71001170 |
| 4 | MP0003303_peritoneal_inflammation | 4.36865254 |
| 5 | MP0001790_abnormal_immune_system | 3.61843686 |
| 6 | MP0005387_immune_system_phenotype | 3.61843686 |
| 7 | MP0005671_abnormal_response_to | 3.59833746 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.32853151 |
| 9 | MP0002723_abnormal_immune_serum | 2.88116288 |
| 10 | MP0006054_spinal_hemorrhage | 2.85641898 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.69481918 |
| 12 | MP0001819_abnormal_immune_cell | 2.63850296 |
| 13 | MP0002398_abnormal_bone_marrow | 2.57330956 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.57050017 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.56448682 |
| 16 | MP0000716_abnormal_immune_system | 2.52000163 |
| 17 | MP0000685_abnormal_immune_system | 2.43535121 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.22952055 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.21568449 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.11176867 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.09134517 |
| 22 | MP0005025_abnormal_response_to | 2.08919371 |
| 23 | MP0002429_abnormal_blood_cell | 2.04489832 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 2.02136649 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.98843764 |
| 26 | MP0002006_tumorigenesis | 1.96610349 |
| 27 | MP0002419_abnormal_innate_immunity | 1.88450564 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.81377814 |
| 29 | MP0005166_decreased_susceptibility_to | 1.80843914 |
| 30 | MP0002722_abnormal_immune_system | 1.80840918 |
| 31 | MP0004947_skin_inflammation | 1.77722067 |
| 32 | MP0005360_urolithiasis | 1.74668340 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.71630353 |
| 34 | MP0003436_decreased_susceptibility_to | 1.69309336 |
| 35 | MP0009764_decreased_sensitivity_to | 1.63168569 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.57974812 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.56844105 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.54703514 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.46810491 |
| 40 | MP0002405_respiratory_system_inflammati | 1.41369091 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.37128615 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.36991258 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.35562390 |
| 44 | MP0000920_abnormal_myelination | 1.34777720 |
| 45 | MP0009785_altered_susceptibility_to | 1.32607674 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.31261494 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.29137562 |
| 48 | MP0005275_abnormal_skin_tensile | 1.22272315 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.22060607 |
| 50 | MP0008004_abnormal_stomach_pH | 1.21173698 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.19628584 |
| 52 | MP0008569_lethality_at_weaning | 1.17594480 |
| 53 | MP0003045_fibrosis | 1.17451902 |
| 54 | MP0003448_altered_tumor_morphology | 1.17012600 |
| 55 | MP0004859_abnormal_synaptic_plasticity | 1.15934422 |
| 56 | MP0005310_abnormal_salivary_gland | 1.15056560 |
| 57 | MP0001851_eye_inflammation | 1.14852819 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.13282767 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.12706269 |
| 60 | MP0006082_CNS_inflammation | 1.08493354 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.08123908 |
| 62 | MP0008260_abnormal_autophagy | 1.06980674 |
| 63 | MP0001853_heart_inflammation | 1.06389000 |
| 64 | MP0003866_abnormal_defecation | 1.05737105 |
| 65 | MP0009046_muscle_twitch | 1.05485572 |
| 66 | MP0003279_aneurysm | 1.04957447 |
| 67 | MP0001873_stomach_inflammation | 1.04954458 |
| 68 | MP0004510_myositis | 1.02914609 |
| 69 | MP0000343_altered_response_to | 1.02683613 |
| 70 | MP0009278_abnormal_bone_marrow | 1.02172025 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.01810859 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 1.01731728 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.01189436 |
| 74 | MP0003075_altered_response_to | 1.01182424 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.00649798 |
| 76 | MP0000249_abnormal_blood_vessel | 1.00329029 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.00260021 |
| 78 | MP0005164_abnormal_response_to | 0.99051186 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.98405685 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.97551989 |
| 81 | MP0002933_joint_inflammation | 0.96176281 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95610120 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.95320147 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.95320147 |
| 85 | MP0005390_skeleton_phenotype | 0.94709259 |
| 86 | MP0000858_altered_metastatic_potential | 0.91601294 |
| 87 | MP0008872_abnormal_physiological_respon | 0.89500446 |
| 88 | MP0003868_abnormal_feces_composition | 0.87823880 |
| 89 | MP0004858_abnormal_nervous_system | 0.87184522 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.86864167 |
| 91 | MP0003690_abnormal_glial_cell | 0.86439643 |
| 92 | MP0008469_abnormal_protein_level | 0.86202786 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.85718191 |
| 94 | MP0005332_abnormal_amino_acid | 0.83930785 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.83731043 |
| 96 | MP0000609_abnormal_liver_physiology | 0.83231061 |
| 97 | MP0003828_pulmonary_edema | 0.82931473 |
| 98 | MP0000490_abnormal_crypts_of | 0.80394700 |
| 99 | MP0001919_abnormal_reproductive_system | 0.79706615 |
| 100 | MP0002133_abnormal_respiratory_system | 0.79328146 |
| 101 | MP0005388_respiratory_system_phenotype | 0.79328146 |
| 102 | MP0005083_abnormal_biliary_tract | 0.78203585 |
| 103 | MP0008057_abnormal_DNA_replication | 0.76875797 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.76624312 |
| 105 | MP0003186_abnormal_redox_activity | 0.76554174 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74867304 |
| 107 | MP0003252_abnormal_bile_duct | 0.73605733 |
| 108 | MP0002254_reproductive_system_inflammat | 0.73290419 |
| 109 | MP0003795_abnormal_bone_structure | 0.73095320 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.72799915 |
| 111 | MP0001666_abnormal_nutrient_absorption | 0.72781337 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.71917934 |
| 113 | MP0000604_amyloidosis | 0.71245019 |
| 114 | MP0001663_abnormal_digestive_system | 0.70516446 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.68848492 |
| 116 | MP0003091_abnormal_cell_migration | 0.68329079 |
| 117 | MP0003879_abnormal_hair_cell | 0.65587852 |
| 118 | MP0002873_normal_phenotype | 0.65404305 |
| 119 | MP0002169_no_abnormal_phenotype | 0.65217030 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.64935446 |
| 121 | MP0002083_premature_death | 0.64470329 |
| 122 | MP0003880_abnormal_central_pattern | 0.63856610 |
| 123 | MP0004036_abnormal_muscle_relaxation | 0.63368298 |
| 124 | MP0001958_emphysema | 0.62124070 |
| 125 | MP0010329_abnormal_lipoprotein_level | 0.61289954 |
| 126 | MP0005365_abnormal_bile_salt | 0.61176542 |
| 127 | MP0009763_increased_sensitivity_to | 0.60945976 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.57806679 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.57569370 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.57112864 |
| 131 | MP0001542_abnormal_bone_strength | 0.56913171 |
| 132 | MP0004885_abnormal_endolymph | 0.55237214 |
| 133 | MP0008874_decreased_physiological_sensi | 0.54509845 |
| 134 | MP0001533_abnormal_skeleton_physiology | 0.53613835 |
| 135 | MP0003633_abnormal_nervous_system | 0.53265370 |
| 136 | MP0005023_abnormal_wound_healing | 0.52878423 |
| 137 | MP0008873_increased_physiological_sensi | 0.52621021 |
| 138 | MP0002168_other_aberrant_phenotype | 0.52363462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 8.95846403 |
| 2 | Agammaglobulinemia (HP:0004432) | 8.88511642 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.41806139 |
| 4 | B lymphocytopenia (HP:0010976) | 8.41806139 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.48302929 |
| 6 | Recurrent bronchitis (HP:0002837) | 6.35495056 |
| 7 | Abnormality of macrophages (HP:0004311) | 6.28699166 |
| 8 | Abnormality of the prostate (HP:0008775) | 6.17419943 |
| 9 | Cellulitis (HP:0100658) | 6.08276743 |
| 10 | Colitis (HP:0002583) | 5.74771413 |
| 11 | Papilloma (HP:0012740) | 5.62863170 |
| 12 | Verrucae (HP:0200043) | 5.62863170 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 5.17768697 |
| 14 | IgM deficiency (HP:0002850) | 5.10069884 |
| 15 | Recurrent viral infections (HP:0004429) | 4.95853426 |
| 16 | Meningitis (HP:0001287) | 4.67415867 |
| 17 | Recurrent pneumonia (HP:0006532) | 4.46800794 |
| 18 | Leukocytosis (HP:0001974) | 4.16180225 |
| 19 | Inflammation of the large intestine (HP:0002037) | 4.10500368 |
| 20 | Thyroiditis (HP:0100646) | 4.09257655 |
| 21 | Chronic sinusitis (HP:0011109) | 4.00168917 |
| 22 | Chronic otitis media (HP:0000389) | 3.95606687 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.93894380 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.71317401 |
| 25 | Recurrent otitis media (HP:0000403) | 3.66799375 |
| 26 | Osteomyelitis (HP:0002754) | 3.65721535 |
| 27 | Abnormality of male internal genitalia (HP:0000022) | 3.60849055 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.57352208 |
| 29 | Bronchitis (HP:0012387) | 3.55366813 |
| 30 | IgG deficiency (HP:0004315) | 3.36625976 |
| 31 | Sepsis (HP:0100806) | 3.34242465 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.33862131 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.23528863 |
| 34 | Emphysema (HP:0002097) | 3.04348199 |
| 35 | Neoplasm of the lung (HP:0100526) | 3.01654697 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.99953590 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 2.97198972 |
| 38 | Skin rash (HP:0000988) | 2.95030405 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.93812950 |
| 40 | Mitral stenosis (HP:0001718) | 2.92417811 |
| 41 | IgA deficiency (HP:0002720) | 2.85855029 |
| 42 | T lymphocytopenia (HP:0005403) | 2.82091627 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.81138235 |
| 44 | Abnormality of T cells (HP:0002843) | 2.79454160 |
| 45 | Vasculitis (HP:0002633) | 2.74752483 |
| 46 | Hematochezia (HP:0002573) | 2.71666128 |
| 47 | Increased IgE level (HP:0003212) | 2.70520748 |
| 48 | Orchitis (HP:0100796) | 2.69484225 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.64242838 |
| 50 | Neoplasm of the respiratory system (HP:0100606) | 2.63300526 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56400302 |
| 52 | Restrictive lung disease (HP:0002091) | 2.56202898 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.54237644 |
| 54 | Peritonitis (HP:0002586) | 2.50785673 |
| 55 | Stomatitis (HP:0010280) | 2.50158404 |
| 56 | Urticaria (HP:0001025) | 2.49177085 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.49077769 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.48857140 |
| 59 | Optic neuritis (HP:0100653) | 2.48857140 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.48631267 |
| 61 | Hemoptysis (HP:0002105) | 2.46294194 |
| 62 | Gingival bleeding (HP:0000225) | 2.46081884 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.42002590 |
| 64 | Combined immunodeficiency (HP:0005387) | 2.38763587 |
| 65 | Lymphopenia (HP:0001888) | 2.38547059 |
| 66 | Abnormality of the peritoneum (HP:0002585) | 2.37925158 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.37858447 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36532753 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.31900232 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.29801836 |
| 71 | Nephritis (HP:0000123) | 2.28278323 |
| 72 | Gingivitis (HP:0000230) | 2.24053379 |
| 73 | Hypermelanotic macule (HP:0001034) | 2.23641501 |
| 74 | Mucosal telangiectasiae (HP:0100579) | 2.22686599 |
| 75 | Chest pain (HP:0100749) | 2.21126108 |
| 76 | Malnutrition (HP:0004395) | 2.21018185 |
| 77 | Increased IgM level (HP:0003496) | 2.19371829 |
| 78 | Acrocyanosis (HP:0001063) | 2.19220058 |
| 79 | Glomerulonephritis (HP:0000099) | 2.18118833 |
| 80 | Xerostomia (HP:0000217) | 2.17508657 |
| 81 | Skin ulcer (HP:0200042) | 2.14424719 |
| 82 | Myositis (HP:0100614) | 2.13322583 |
| 83 | Granulocytopenia (HP:0001913) | 2.12508467 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.11966616 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.06146145 |
| 86 | Recurrent skin infections (HP:0001581) | 2.05741377 |
| 87 | Hypertensive crisis (HP:0100735) | 2.03979019 |
| 88 | Epistaxis (HP:0000421) | 2.03269054 |
| 89 | Deep venous thrombosis (HP:0002625) | 2.00909710 |
| 90 | Premature loss of primary teeth (HP:0006323) | 2.00010531 |
| 91 | Hypoproteinemia (HP:0003075) | 1.98873891 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93846518 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93846518 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93114597 |
| 95 | Nasal polyposis (HP:0100582) | 1.91251548 |
| 96 | Acute hepatic failure (HP:0006554) | 1.90594442 |
| 97 | Macroorchidism (HP:0000053) | 1.89343532 |
| 98 | Neutropenia (HP:0001875) | 1.88786359 |
| 99 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88734204 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 1.88029389 |
| 101 | Eosinophilia (HP:0001880) | 1.87538959 |
| 102 | Encephalitis (HP:0002383) | 1.86843761 |
| 103 | Abnormality of complement system (HP:0005339) | 1.85116763 |
| 104 | Stroke (HP:0001297) | 1.83945296 |
| 105 | Chronic diarrhea (HP:0002028) | 1.83820223 |
| 106 | Purpura (HP:0000979) | 1.82932137 |
| 107 | Arthralgia (HP:0002829) | 1.80781864 |
| 108 | Nonimmune hydrops fetalis (HP:0001790) | 1.76927073 |
| 109 | Bronchiectasis (HP:0002110) | 1.76696579 |
| 110 | Papilledema (HP:0001085) | 1.74389833 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.72974678 |
| 112 | Eczematoid dermatitis (HP:0000976) | 1.71548774 |
| 113 | Lymphoma (HP:0002665) | 1.69706843 |
| 114 | Thrombocytosis (HP:0001894) | 1.68405447 |
| 115 | Colon cancer (HP:0003003) | 1.68280419 |
| 116 | Leukopenia (HP:0001882) | 1.65428503 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.64393318 |
| 118 | Limb hypertonia (HP:0002509) | 1.63321724 |
| 119 | Teleangiectasia of the skin (HP:0100585) | 1.63236943 |
| 120 | Conjunctival hamartoma (HP:0100780) | 1.60337305 |
| 121 | Mediastinal lymphadenopathy (HP:0100721) | 1.59031434 |
| 122 | Abnormal gallbladder morphology (HP:0012437) | 1.58450298 |
| 123 | Cholelithiasis (HP:0001081) | 1.57186704 |
| 124 | Dysostosis multiplex (HP:0000943) | 1.54729632 |
| 125 | Camptodactyly of toe (HP:0001836) | 1.53399405 |
| 126 | Keratoconjunctivitis (HP:0001096) | 1.50226817 |
| 127 | Abnormality of eosinophils (HP:0001879) | 1.49029256 |
| 128 | Dehydration (HP:0001944) | 1.47896768 |
| 129 | Small epiphyses (HP:0010585) | 1.46711569 |
| 130 | Hyperventilation (HP:0002883) | 1.44475071 |
| 131 | Viral hepatitis (HP:0006562) | 1.42051795 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.40701694 |
| 133 | Progressive macrocephaly (HP:0004481) | 1.39755656 |
| 134 | Supranuclear gaze palsy (HP:0000605) | 1.39654972 |
| 135 | Chondrocalcinosis (HP:0000934) | 1.39310450 |
| 136 | Acute encephalopathy (HP:0006846) | 1.38678865 |
| 137 | Hypergammaglobulinemia (HP:0010702) | 1.38572576 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.38411877 |
| 139 | Abnormal platelet volume (HP:0011876) | 1.37505395 |
| 140 | Obstructive lung disease (HP:0006536) | 1.37343390 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.37343390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.47274249 |
| 2 | MAP4K1 | 4.91227581 |
| 3 | PKN2 | 3.29804901 |
| 4 | RIPK4 | 3.21812311 |
| 5 | GRK6 | 3.00862905 |
| 6 | CAMKK2 | 2.69179791 |
| 7 | TXK | 2.61202014 |
| 8 | MAP3K10 | 2.51657733 |
| 9 | SYK | 2.51657003 |
| 10 | BRSK2 | 2.40709827 |
| 11 | SIK2 | 2.39985136 |
| 12 | IRAK1 | 2.28724094 |
| 13 | TYK2 | 2.27992851 |
| 14 | FLT3 | 2.20118627 |
| 15 | CSF1R | 2.19288816 |
| 16 | MAP3K13 | 2.12389467 |
| 17 | KIT | 2.06774419 |
| 18 | MAP3K14 | 2.01329069 |
| 19 | BTK | 1.85931073 |
| 20 | PRPF4B | 1.82665822 |
| 21 | BLK | 1.77308356 |
| 22 | LYN | 1.73575916 |
| 23 | IRAK2 | 1.72828254 |
| 24 | IRAK4 | 1.71221068 |
| 25 | BCKDK | 1.64584584 |
| 26 | MST1R | 1.60840194 |
| 27 | FES | 1.58882524 |
| 28 | PRKCH | 1.55946682 |
| 29 | PDK2 | 1.53278398 |
| 30 | TBK1 | 1.50938921 |
| 31 | TAOK3 | 1.49169827 |
| 32 | ZAP70 | 1.47836720 |
| 33 | JAK1 | 1.47405279 |
| 34 | EIF2AK3 | 1.46557373 |
| 35 | BUB1 | 1.44830849 |
| 36 | ITK | 1.41962299 |
| 37 | CLK1 | 1.41337349 |
| 38 | PIK3CG | 1.41171968 |
| 39 | FRK | 1.40922099 |
| 40 | MAP3K4 | 1.40126161 |
| 41 | IRAK3 | 1.38574348 |
| 42 | NEK2 | 1.35244030 |
| 43 | NME2 | 1.32992457 |
| 44 | STK10 | 1.30409815 |
| 45 | SIK1 | 1.27136173 |
| 46 | FGFR3 | 1.27000076 |
| 47 | EPHA3 | 1.25996281 |
| 48 | FGFR2 | 1.24272904 |
| 49 | HCK | 1.23818553 |
| 50 | MET | 1.22624444 |
| 51 | HIPK2 | 1.16589230 |
| 52 | MST4 | 1.14922277 |
| 53 | BMX | 1.09554192 |
| 54 | PIK3CA | 1.08778082 |
| 55 | PRKCQ | 1.03801084 |
| 56 | TTN | 1.02741308 |
| 57 | PIM1 | 1.01499412 |
| 58 | FGFR4 | 0.98431692 |
| 59 | LRRK2 | 0.96374863 |
| 60 | LCK | 0.92178093 |
| 61 | RIPK1 | 0.91705677 |
| 62 | TGFBR2 | 0.89880565 |
| 63 | EEF2K | 0.88808821 |
| 64 | EPHB1 | 0.88760212 |
| 65 | UHMK1 | 0.84870333 |
| 66 | JAK3 | 0.83155889 |
| 67 | MATK | 0.82926477 |
| 68 | IKBKB | 0.82157334 |
| 69 | MAP3K1 | 0.81352318 |
| 70 | KSR2 | 0.80815085 |
| 71 | BMPR2 | 0.80141545 |
| 72 | PRKD1 | 0.79604838 |
| 73 | MAP3K9 | 0.79149311 |
| 74 | SIK3 | 0.76540933 |
| 75 | STK24 | 0.74704847 |
| 76 | CSK | 0.72857429 |
| 77 | FYN | 0.72595138 |
| 78 | MAP2K3 | 0.72273784 |
| 79 | ALK | 0.70442278 |
| 80 | IKBKE | 0.69347053 |
| 81 | PKN1 | 0.65774973 |
| 82 | IGF1R | 0.64930262 |
| 83 | TAOK2 | 0.64552828 |
| 84 | PDGFRA | 0.62790451 |
| 85 | MAPK12 | 0.58750799 |
| 86 | MARK3 | 0.58742934 |
| 87 | MAP3K3 | 0.56082227 |
| 88 | PRKCD | 0.55250878 |
| 89 | MAPK4 | 0.53449041 |
| 90 | CSNK1A1L | 0.51406380 |
| 91 | FER | 0.51389459 |
| 92 | JAK2 | 0.50895038 |
| 93 | BRSK1 | 0.49405901 |
| 94 | CSNK1G3 | 0.49293156 |
| 95 | NEK1 | 0.49179475 |
| 96 | RET | 0.48918758 |
| 97 | GRK1 | 0.48488907 |
| 98 | TEC | 0.48482586 |
| 99 | ADRBK2 | 0.45758158 |
| 100 | CDC42BPA | 0.45746438 |
| 101 | TLK1 | 0.45007424 |
| 102 | NEK9 | 0.44942778 |
| 103 | MAP3K5 | 0.43593550 |
| 104 | MAPK7 | 0.42259635 |
| 105 | MAPKAPK3 | 0.41942061 |
| 106 | CSNK1G2 | 0.41388995 |
| 107 | FGR | 0.40264737 |
| 108 | TAOK1 | 0.40137083 |
| 109 | INSR | 0.37329991 |
| 110 | NTRK3 | 0.37103308 |
| 111 | TGFBR1 | 0.36081117 |
| 112 | ABL1 | 0.35699926 |
| 113 | NEK6 | 0.35485144 |
| 114 | RPS6KA6 | 0.35377401 |
| 115 | PDK1 | 0.34685655 |
| 116 | PDPK1 | 0.34509078 |
| 117 | CDK12 | 0.33227775 |
| 118 | DDR2 | 0.32943173 |
| 119 | STK4 | 0.32053459 |
| 120 | RPS6KL1 | 0.31408658 |
| 121 | RPS6KC1 | 0.31408658 |
| 122 | CHUK | 0.29532658 |
| 123 | MAP3K8 | 0.29489973 |
| 124 | AKT3 | 0.29257442 |
| 125 | MAP3K7 | 0.28919268 |
| 126 | CAMKK1 | 0.28861336 |
| 127 | MAPK11 | 0.28004782 |
| 128 | RPS6KB2 | 0.27747553 |
| 129 | PRKD2 | 0.26693556 |
| 130 | MAPKAPK2 | 0.26379383 |
| 131 | TNK2 | 0.26309245 |
| 132 | MAP3K11 | 0.24462427 |
| 133 | NLK | 0.23508391 |
| 134 | CDK5 | 0.23487417 |
| 135 | CSNK1G1 | 0.23261436 |
| 136 | SRC | 0.22799781 |
| 137 | NME1 | 0.22367238 |
| 138 | MAPK3 | 0.22333057 |
| 139 | CDK6 | 0.22135301 |
| 140 | EGFR | 0.21609326 |
| 141 | CDK15 | 0.21159818 |
| 142 | PRKAA2 | 0.20225083 |
| 143 | GRK5 | 0.19037137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.92294751 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.39911571 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.31801261 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.02658315 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.02818792 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.59720067 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35819628 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.32314345 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.93399628 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.78905036 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.72558604 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.63827568 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59698006 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46046588 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42643373 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42119829 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34923898 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33365626 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27209019 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24853179 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23494303 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23308193 |
| 23 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.22091024 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.17166786 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17059704 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16603702 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16317202 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13018506 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11054932 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07547910 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07194138 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05555019 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05170512 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04487625 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02287154 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.98654900 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 0.96328184 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 0.95499240 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91890168 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 0.89894657 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87716771 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87097757 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86474012 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.85913516 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83292120 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82920158 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.82141040 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79878382 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.79456391 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.78441538 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 0.78101423 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74885903 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74389903 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 0.74351709 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72030857 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71013983 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68850116 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66941581 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64111585 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63760865 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62671432 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62125349 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61483338 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60228320 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59873687 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58218884 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57078414 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54753116 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54027776 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53845862 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51899280 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51667744 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50951079 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50481745 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.50441892 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50097508 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50048776 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48466043 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46592036 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46424299 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46305501 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.46283634 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45720039 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45443273 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.44543837 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44344205 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44286739 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.44194655 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43698702 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43028646 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41301629 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41186216 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.38582520 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.38096689 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37570748 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37263624 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.36887237 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36573483 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.36017828 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35951436 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35728035 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34767643 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32624591 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31747261 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.31587695 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31556020 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31197034 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31034164 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30943886 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | 0.30747604 |
| 111 | Hepatitis B_Homo sapiens_hsa05161 | 0.30570667 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29685860 |
| 113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29304914 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28280016 |
| 115 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27703318 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.27675747 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26996647 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26960209 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26298578 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26007347 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25868765 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25126891 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.25083483 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24857465 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23999247 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23648909 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22447185 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.22201521 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22033890 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.21951820 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21681864 |
| 132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21509363 |
| 133 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21459213 |
| 134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20621120 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20282441 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20209007 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20207170 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20183607 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20163554 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19759633 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.19573801 |
| 142 | GABAergic synapse_Homo sapiens_hsa04727 | 0.19486550 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19333570 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18010971 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.17747335 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17614096 |

